Back to Treatments

Treatment

Talimogene laherparepvec (T-VEC)

1
Conditions
4
Trials
1,200
Participants
60%
Average Safety

Condition Evidence

Malignant skin melanoma

4 trials · 1,200 participants

75% effectiveness · 60% safety
Talimogene laherparepvec (T-VEC) | DFDA